About
Investor and Media Contacts:
ir@clearsidebio.com
(678) 430-8206
Source:
![](https://ml.globenewswire.com/media/NWM3ODI1ZWItMjZiNS00YzMyLWJlNjktMzFkYjMwNzRmYTAwLTEwMjI3MzU=/tiny/Clearside-Biomedical-Inc-.png)
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | -3.25% |
|
-2.46% | +1.71% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
About
Investor and Media Contacts:
ir@clearsidebio.com
(678) 430-8206
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+1.71% | 88.93M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |